ADvantage Therapeutics, Inc.

New Filing
CIK: 0001869338·Other Health Care·DELAWARE·Filed: Jun 15, 2022
Total Offering

$7,500,000

Amount Sold

$275,000

Investors

3

First Sale

May 31, 2022

Offering Details

Type
Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2021
Non-Accredited Investors
No

Related Persons

NameRole
Agustin Fernandez Santana III
Related Person
Jeffrey B. Madden
Related Person
Frank Mattner
Related Person
Walter Schmidt
Related Person
David Buchsbaum
Related Person

Company

ADvantage Therapeutics, Inc.

195 NW 40th Street

MIAMI, FL, 33127

6178323062

SEC Filing

0001869338-22-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free